Galp Energia, SGPS, S.A. (ELI:GALP)

Lumos Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,229	2,285	2,200	2,432	1,942	1,678
Cash & Short-Term Investments	2,229	2,285	2,200	2,432	1,942	1,678
Cash Growth	-5.19%	3.86%	-9.54%	25.23%	15.73%	14.93%
Accounts Receivable	1,723	1,590	1,742	1,865	1,690	964
Other Receivables	473	452	430	397	464	713
Receivables	2,231	2,083	2,213	2,296	2,154	1,719
Inventory	1,263	1,101	1,447	1,361	1,007	708
Other Current Assets	754	2,042	856	952	1,105	230
Total Current Assets	6,477	7,511	6,716	7,041	6,208	4,335
Property, Plant & Equipment	7,184	7,409	7,659	6,816	6,248	5,880
Long-Term Investments	97	109	284	463	396	486
Goodwill	44	44	44	70	85	85
Other Intangible Assets	647	695	659	672	645	532
Long-Term Accounts Receivable	80	53	48	64	67	68
Long-Term Deferred Tax Assets	660	669	615	559	485	509
Long-Term Deferred Charges	15	19	32	32	87	96
Other Long-Term Assets	303	307	314	277	280	171
Total Assets	15,506	16,817	16,606	16,096	14,912	12,492
Accounts Payable	1,065	945	1,268	1,005	811	650
Accrued Expenses	1,187	1,281	1,202	1,047	884	567
Short-Term Debt	19	11	129	11	131	2
Current Portion of Long-Term Debt	600	356	446	789	1,174	537
Current Portion of Leases	220	233	267	182	164	166
Current Income Taxes Payable	220	332	311	361	-	-
Current Unearned Revenue	69	26	109	21	30	14
Other Current Liabilities	581	1,181	644	898	1,345	312
Total Current Liabilities	3,961	4,365	4,376	4,314	4,539	2,248
Long-Term Debt	3,025	3,125	3,026	3,187	2,995	3,204
Long-Term Leases	1,083	1,182	1,543	1,095	1,015	923
Long-Term Unearned Revenue	22	22	21	10	11	11
Long-Term Deferred Tax Liabilities	435	579	476	555	653	479
Other Long-Term Liabilities	1,661	1,684	1,610	1,566	1,429	1,146
Total Liabilities	10,403	11,178	11,277	10,979	10,942	8,392
Common Stock	753	753	773	815	829	829
Additional Paid-In Capital	-	-	-	82	82	82
Retained Earnings	2,831	2,418	2,187	1,701	813	1,282
Treasury Stock	-220	-47	-	-	-	-
Comprehensive Income & Other	964	1,565	1,449	1,563	1,328	967
Total Common Equity	4,328	4,689	4,409	4,161	3,052	3,160
Minority Interest	775	950	920	956	918	940
Shareholders' Equity	5,103	5,639	5,329	5,117	3,970	4,100
Total Liabilities & Equity	15,506	16,817	16,606	16,096	14,912	12,492
Total Debt	4,947	4,907	5,411	5,264	5,479	4,832
Net Cash (Debt)	-2,718	-2,622	-3,211	-2,832	-3,537	-3,154
Net Cash Per Share	-3.63	-3.45	-4.03	-3.48	-4.27	-3.78
Filing Date Shares Outstanding	737.76	750.27	773.08	815.11	829.25	829.25
Total Common Shares Outstanding	737.76	750.27	773.08	815.11	829.25	829.25
Working Capital	2,516	3,146	2,340	2,727	1,669	2,087
Book Value Per Share	5.87	6.25	5.70	5.10	3.68	3.81
Tangible Book Value	3,637	3,950	3,706	3,419	2,322	2,543
Tangible Book Value Per Share	4.93	5.26	4.79	4.19	2.80	3.07
Land	1,317	1,307	1,301	1,261	1,253	1,224
Machinery	11,665	12,024	11,705	11,454	11,697	10,837
Construction In Progress	2,878	2,790	2,407	1,910	1,794	1,416

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.